MetLife (MET) reported $19.68 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 4.5%. EPS of $2.42 for the same period compares to $1.96 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $19.22 billion, representing a surprise of +2.4%. The company delivered an EPS surprise of +7.54%, with the consensus EPS estimate being $2.25.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how MetLife performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Institutional Client AUM: $313.16 billion compared to the $327.51 billion average estimate based on three analysts. Total AUM: $736.29 billion versus $712.22 billion estimated by three analysts on average. METLIFE INVESTMENT MANAGEMENT(MIM)-GA AUM: $423.13 billion versus the three-analyst average estimate of $384.71 billion. Adjusted Revenue- Corporate & other- Net investment income: $953 million compared to the $1.09 billion average estimate based on three analysts. The reported number represents a change of +1242.3% year over year. Adjusted Revenue- Corporate & other- Premiums: $592 million versus $652.83 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6477.8% change. Adjusted Revenue- EMEA- Net investment income: $67 million versus the three-analyst average estimate of $66.84 million. The reported number represents a year-over-year change of +15.5%. Adjusted Revenue- Latin America- Net investment income: $409 million versus the three-analyst average estimate of $457.71 million. The reported number represents a year-over-year change of +0.5%. Revenue- Other Revenues: $852 million compared to the $705.49 million average estimate based on four analysts. The reported number represents a change of +24% year over year. Revenue- Net investment income: $5.36 billion compared to the $5.71 billion average estimate based on four analysts. The reported number represents a change of +9.6% year over year. Revenue- Universal life and investment-type product policy fees: $1.34 billion compared to the $1.29 billion average estimate based on four analysts. The reported number represents a change of +9.3% year over year. Revenue- Premiums: $12.12 billion compared to the $11.49 billion average estimate based on four analysts. The reported number represents a change of +3.4% year over year. Total Adjusted Revenue- Group Benefits: $6.89 billion versus the three-analyst average estimate of $6.92 billion. The reported number represents a year-over-year change of +2.2%.View all Key Company Metrics for MetLife here>>>
Shares of MetLife have returned +12.2% over the past month versus the Zacks S&P 500 composite's +10.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MetLife, Inc. (MET): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).